Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

RSV vaccine study aims to make shots easier to store and use

NCT ID NCT06473519

First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 24 times

Summary

This study tested an RSV vaccine in 453 healthy women aged 18-49. The goal was to see if a multidose vial with a preservative works as well as a single-dose vial. Participants received one shot and were followed for about 6 weeks to check safety and immune response.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Clinical Research Atlanta

    Stockbridge, Georgia, 30281, United States

  • Clinical Research Prime

    Idaho Falls, Idaho, 83404, United States

  • Clinical Research Prime Rexburg

    Rexburg, Idaho, 83440, United States

  • Clinical Trials of Texas, LLC dba Flourish Research

    San Antonio, Texas, 78229, United States

  • Headlands Research - Detroit

    Southfield, Michigan, 48034, United States

  • Qps-Mra, Llc

    South Miami, Florida, 33143, United States

Conditions

Explore the condition pages connected to this study.